1. Home
  2. MLR vs MYGN Comparison

MLR vs MYGN Comparison

Compare MLR & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Miller Industries Inc.

MLR

Miller Industries Inc.

N/A

Current Price

$46.39

Market Cap

617.4M

ML Signal

N/A

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

N/A

Current Price

$5.44

Market Cap

523.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MLR
MYGN
Founded
1990
1991
Country
United States
United States
Employees
N/A
2700
Industry
Construction/Ag Equipment/Trucks
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
617.4M
523.7M
IPO Year
2004
1996

Fundamental Metrics

Financial Performance
Metric
MLR
MYGN
Price
$46.39
$5.44
Analyst Decision
Buy
Hold
Analyst Count
2
9
Target Price
★ $53.00
$5.90
AVG Volume (30 Days)
65.0K
★ 1.7M
Earning Date
11-04-2026
11-04-2026
Dividend Yield
★ 1.78%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 1.21
N/A
Revenue
★ $790,271,000.00
$771,400,000.00
Revenue This Year
$11.69
N/A
Revenue Next Year
$14.94
N/A
P/E Ratio
$39.11
★ N/A
Revenue Growth
N/A
★ 2.33
52 Week Low
$36.23
$2.74
52 Week High
$59.70
$8.09

Technical Indicators

Market Signals
Indicator
MLR
MYGN
Relative Strength Index (RSI) 35.42 46.99
Support Level $45.95 $4.19
Resistance Level $49.35 $5.52
Average True Range (ATR) 1.95 0.30
MACD -0.10 -0.13
Stochastic Oscillator 23.14 0.00

Price Performance

Historical Comparison
MLR
MYGN

About MLR Miller Industries Inc.

Miller Industries Inc is a manufacturer of Towing and Recovery Equipment. The company designs and manufactures bodies of car carriers and wreckers, which are installed on chassis manufactured by third parties, and sold to customers. Its product lines include car carriers, light duty, heavy duty, rotators, special transport, military, wreckers, and transport trailers. It sells products under various brands including Century, Vulcan, Chevron, Holmes, Challenger, Champion, Jige, Boniface, Omars, Titan, and Eagle.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: